Clinical Trial: Comparative Study of Non-Inferiority Immunogenicity of GP40321 and Apidra (R) SoloStar (R) in Type 1 Diabetes Mellitus Patients

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07070752) titled 'Comparative Study of Non-Inferiority Immunogenicity of GP40321 and Apidra (R) SoloStar (R) in Type 1 Diabetes Mellitus Patients' on July 09.

Brief Summary: The goal of this clinical trial is to demonstrate non-inferiority immunogenicity of GP40321 and Apidra (R) SoloStar (R) at a concentration of 100 U/ml in type 1 diabetes mellitus patients. The main questions it aims to answer are:

* What is the immunogenicity of GP40321 and Apidra (R) SoloStar (R)?

* What is the efficacy and safety of GP40321 and Apidra (R) SoloStar (R)?

Researchers will compare the immunogenicity, efficacy and safety parameters of GP40321 and Apidra (R) SoloS...